Dennis Ensing

Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada.

Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO.

Techalliance engages in the provision of networking opportunities for entrepreneurs and employees. It offers venture growth and corporate innovations, peer-2-peer groups, digital main street, burst, and proteus innovation competition. The company was founded in 2002 and is headquartered in London, Canada.

General Media Ventures Ltd. engages in developing and delivering platform-defining social video game experiences. The company is headquartered in Bath, the United Kingdom.

Southwestern Ontario Angel Group provides investment services. The company was founded in 2008 and is headquartered in London, Canada.

MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada.

Sensory Technologies, Inc. develops medical software to prevent and replace medical treatment within private and public healthcare facilities. Its products include eShift and eClinic. The company was founded by Patrick Blanshard and Elaine Knight and is headquartered in London, Canada.